Krystal Biotech, Inc
  • Focus
    • Our Focus
    • Pipeline
    • Dystrophic EB
    • Netherton Syndrome
    • TGM1-deficient ARCI
    • Cystic Fibrosis
    • Aesthetic Skin Conditions
    • Chronic Skin Diseases
  • Patients and Families
    • Our gene therapy
    • Our STAR-D platform
    • Our Targets
    • Patient Advocacy
  • Medical Professionals
  • About Us
  • Investors
  • Contact
    • Contact Us
    • Careers
Contact Us
Homepage-1

We are leading
the development
of corrective and
redosable gene
therapies to offer
hope to patients
facing debilitating
rare diseases.

Learn More
Homepage-1 - copy

At Krystal, we
are driven by
our mission to
develop innovative
gene therapies to
dramatically improve
people’s lives.

Learn More
previous arrow
next arrow

Dystrophic Epidermolysis Bullosa

B-VEC

READ MORE

TGM1-deficient ARCI

KB105

READ MORE

Cystic Fibrosis

KB407

READ MORE

Netherton Syndrome

KB104

READ MORE

Additional Dermatological Indications

Our Therapies

READ MORE

Quick Links

Focus
Patients and Families
Medical Professionals
About Us
Investors
Contact


© Krystal Biotech All Rights Reserved
View Our Privacy Policy
View Our Terms of Use

Krystal Biotech, Inc.

2100 Wharton St. #701
Pittsburgh, PA 15203
412-586-5830
inquiries@krystalbio.com